RASD Health Policy | Health Policy Research & Analysis in MENA
🇦🇪United Arab Emirates, Abu Dhabi
Listing Description
RASD Health Policy is an independent health policy research and monitoring platform focused on the Middle East and North Africa (MENA). RASD provides insights into healthcare policies, public health regulations, healthcare legislation, health systems governance, and regional healthcare reforms. Through policy analysis, evidence-based research, and professional dialogue, RASD aims to support researchers, healthcare professionals, policymakers, and institutions in understanding developments in public health and healthcare systems.
Contact Information
- Email resolvedsinus888@outlook.com
- Phone +971500000000
- WhatsApp +971500000000
- Website resolvedsinus.com
Location
Frequently Asked Questions
What is EverOpen+?
EverOpen+ is an advanced sinus surgery approach that combines endoscopic treatment of affected sinus drainage pathways with a dissolvable, drug-releasing implant. The implant delivers anti-inflammatory medication locally during healing.
What is a drug-releasing sinus implant?
It is a temporary device designed to gradually release anti-inflammatory medication directly to the treated sinus area after surgery, helping manage swelling during recovery.
How long does the implant take to dissolve?
The implant gradually dissolves in approximately 45–60 days. It is not intended to remain permanently.
How is EverOpen+ different from traditional sinus surgery?
In addition to improving affected sinus drainage pathways, EverOpen+ focuses on managing postoperative inflammation through localized anti-inflammatory treatment.
Write a Review
You need to be logged in to write a review.
Log in to Review
